| 000 | 00951 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515214210.0 | ||
| 264 | 0 | _c20100323 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeachey, David T | |
| 245 | 0 | 0 |
_aDabigatran versus warfarin for venous thromboembolism. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMar 2010 |
||
| 300 |
_a1050; author reply 1050-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnticoagulants _xeconomics |
| 650 | 0 | 4 |
_aBenzimidazoles _xeconomics |
| 650 | 0 | 4 | _aDabigatran |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 |
_aPyridines _xeconomics |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xdrug therapy |
| 650 | 0 | 4 |
_aWarfarin _xeconomics |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 362 _gno. 11 _gp. 1050; author reply 1050-1 |
|
| 999 |
_c19665509 _d19665509 |
||